Home Data Calendar Blog

PLRX

Tables

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Common Stock Value		0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NA
dei: Entity Common Stock Shares Outstanding		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Weighted Average Number Of Diluted Shares Outstanding		NA	59.69	59.17	56.06	NA	46.80	36.17	36.12	NA	35.91	35.75	35.65	NA	35.45	12.25	0.27
Weighted Average Number Of Shares Outstanding Basic		NA	59.69	59.17	56.06	NA	46.80	36.17	36.12	NA	35.91	35.75	35.65	NA	35.45	12.25	0.27
Earnings Per Share Basic		-0.69	-0.70	-0.70	-0.67	-0.72	-0.65	-0.82	-0.78	-0.68	-0.75	-0.64	-0.64	-0.59	-0.47	-1.39	NA
Earnings Per Share Diluted		-0.69	-0.70	-0.70	-0.67	-0.72	-0.65	-0.82	-0.78	-0.68	-0.75	-0.64	-0.64	-0.59	-0.47	-1.39	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Revenue From Contract With Customer Excluding Assessed Tax		0.00	0.00	0.25	1.33	1.97	1.48	4.99	1.25	2.00	1.61	1.79	2.17	4.46	4.81	3.60	28.94
Operating Expenses		47.04	47.69	47.58	43.43	39.37	33.43	34.63	29.46	26.60	28.72	24.69	25.09	23.48	21.48	20.58	17.93
Research And Development Expense		33.18	32.34	33.00	29.27	25.11	24.61	26.34	20.88	18.75	21.05	19.22	18.53	17.85	16.88	17.54	13.92
General And Administrative Expense		13.85	15.35	14.57	14.15	14.25	8.82	8.30	8.58	7.85	7.67	5.47	6.57	5.63	4.59	3.04	4.01
Operating Income Loss		-47.04	-47.69	-47.33	-42.09	-37.40	-31.95	-29.64	-28.21	-24.60	-27.11	-22.90	-22.92	-19.02	-16.66	-16.98	11.01
Interest Expense		0.32	0.32	0.32	0.31	0.32	0.30	0.17	NA	NA	NA	NA	NA	NA	NA	NA	NA
Interest Paid Net		0.28	0.29	0.29	0.28	0.28	0.26	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Allocated Share Based Compensation Expense		9.15	10.36	13.05	11.92	10.86	4.81	3.40	3.53	2.77	2.81	2.28	2.58	1.51	1.17	0.79	0.42
Net Income Loss		-41.11	-41.49	-41.19	-37.55	-35.06	-30.61	-29.55	-28.10	-24.53	-27.05	-22.83	-22.86	-19.03	-16.53	-17.00	11.03
Comprehensive Income Net Of Tax		-38.86	-41.15	-42.10	-36.92	-34.56	-31.81	-29.86	-28.85	-24.69	-27.05	-22.84	-22.84	-19.04	-16.52	-17.09	11.09

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Assets		512.15	540.46	574.89	597.88	350.61	377.18	184.62	197.02	221.22	234.12	255.72	275.25	295.53	312.32	328.80	NA
Liabilities		38.58	37.42	41.83	35.96	37.27	40.19	36.83	23.23	22.16	13.68	11.74	11.09	12.46	11.98	12.99	NA
Liabilities And Stockholders Equity		512.15	540.46	574.89	597.88	350.61	377.18	184.62	197.02	221.22	234.12	255.72	275.25	295.53	312.32	328.80	NA
Stockholders Equity		473.58	503.05	533.07	561.92	313.34	336.99	147.79	173.79	199.06	220.44	243.98	264.17	283.06	300.35	315.82	-64.75

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Assets Current		505.50	534.34	565.70	588.23	340.31	365.96	173.53	185.36	209.44	228.58	250.72	270.54	290.75	307.73	324.32	NA
Cash And Cash Equivalents At Carrying Value		63.23	57.68	54.95	102.53	33.69	44.62	25.07	32.55	51.66	45.23	35.19	50.82	50.88	55.22	178.46	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		64.72	57.68	54.95	102.53	33.68	44.62	25.07	32.55	51.66	45.23	35.19	50.82	50.88	55.22	178.46	113.37
Short Term Investments		431.01	465.93	500.21	474.79	297.50	315.62	138.53	145.74	148.93	175.81	208.79	213.28	226.01	238.78	134.01	NA
Prepaid Expense And Other Assets Current		11.26	10.64	8.88	7.53	7.06	4.16	4.86	5.75	6.76	5.85	4.83	4.18	4.50	6.51	8.17	NA
Available For Sale Securities Debt Securities		488.25	518.18	548.02	557.83	325.81	343.06	153.10	163.05	183.76	203.79	233.78	243.84	263.70	273.72	273.92	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Property Plant And Equipment Gross		12.25	12.19	12.10	11.49	11.33	11.19	10.46	10.21	9.62	9.31	8.59	8.11	7.81	7.29	6.85	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		8.68	8.22	7.77	7.29	6.84	6.39	5.93	5.47	5.02	4.61	4.22	3.85	3.49	3.15	2.82	NA
Property Plant And Equipment Net		3.57	3.97	4.33	4.20	4.49	4.80	4.53	4.74	4.61	4.71	4.37	4.27	4.32	4.14	4.03	NA
Other Assets Noncurrent		0.39	0.39	0.67	0.64	0.39	0.40	0.91	0.83	0.84	0.83	0.63	0.45	0.45	0.45	0.45	NA
Available For Sale Debt Securities Amortized Cost Basis		487.91	520.09	550.26	559.16	327.77	345.51	154.36	164.00	183.96	203.83	233.81	243.85	263.73	273.73	273.95	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Liabilities Current		28.52	27.39	29.52	23.15	23.91	26.16	22.55	18.31	16.83	12.93	10.93	10.25	11.60	11.03	12.04	NA
Accounts Payable Current		4.53	3.36	2.31	1.42	1.58	3.21	3.12	4.68	2.97	2.60	2.76	2.89	2.02	3.14	2.48	NA
Accrued Liabilities Current		10.22	8.31	6.76	NA	8.66	20.31	17.39	11.63	11.99	10.32	8.17	7.36	9.58	7.89	9.55	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Long Term Debt		10.05	10.02	9.99	9.96	9.93	9.90	9.87	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating Lease Liability Noncurrent		NA	NA	2.32	2.85	3.43	4.13	4.41	4.92	5.33	NA	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Stockholders Equity		473.58	503.05	533.07	561.92	313.34	336.99	147.79	173.79	199.06	220.44	243.98	264.17	283.06	300.35	315.82	-64.75
Common Stock Value		0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NA
Additional Paid In Capital Common Stock		972.97	963.59	952.45	939.21	653.71	642.79	421.78	417.93	414.35	411.04	407.52	404.87	400.92	NA	NA	NA
Retained Earnings Accumulated Deficit		-499.75	-458.64	-417.15	-375.96	-338.41	-303.35	-272.74	-243.19	-215.09	-190.56	-163.51	-140.68	-117.83	-98.80	-82.27	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		0.34	-1.91	-2.24	-1.33	-1.96	-2.45	-1.26	-0.95	-0.20	-0.04	-0.03	-0.02	-0.03	-0.02	-0.03	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		NA	10.36	13.05	11.92	NA	4.81	3.40	3.53	NA	2.81	2.28	2.58	NA	1.17	0.79	0.42

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Operating Activities		-25.10	-36.22	-24.76	-30.28	-31.24	-18.50	-24.40	-20.50	-19.86	-22.51	-19.40	-13.66	-16.48	-15.79	7.77	-12.77
Net Cash Provided By Used In Investing Activities		31.92	38.25	-22.98	-174.21	20.02	-178.25	6.50	1.53	25.78	32.10	3.58	12.23	11.91	-105.08	-106.32	-11.37
Net Cash Provided By Used In Financing Activities		0.22	0.70	0.16	273.33	0.28	216.30	10.43	-0.15	0.52	0.45	0.19	1.37	0.24	-2.37	163.64	51.70

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Operating Activities		-25.10	-36.22	-24.76	-30.28	-31.24	-18.50	-24.40	-20.50	-19.86	-22.51	-19.40	-13.66	-16.48	-15.79	7.77	-12.77
Net Income Loss		-41.11	-41.49	-41.19	-37.55	-35.06	-30.61	-29.55	-28.10	-24.53	-27.05	-22.83	-22.86	-19.03	-16.53	-17.00	11.03
Increase Decrease In Accounts Receivable		0.00	-1.58	-1.72	1.31	0.50	-3.51	3.74	-0.75	0.39	-0.22	-0.34	-7.11	2.15	3.53	-28.16	24.71
Increase Decrease In Accounts Payable		1.17	1.06	0.88	-0.14	-1.60	0.05	-1.57	1.77	0.49	-0.34	0.08	0.67	-0.90	1.15	-0.50	1.18
Share Based Compensation		9.15	10.36	13.05	11.92	10.86	4.81	3.40	3.53	2.77	2.81	2.28	2.58	1.51	1.17	0.79	0.42

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Investing Activities		31.92	38.25	-22.98	-174.21	20.02	-178.25	6.50	1.53	25.78	32.10	3.58	12.23	11.91	-105.08	-106.32	-11.37
Payments To Acquire Property Plant And Equipment		0.06	0.09	0.60	0.16	0.17	0.70	0.25	0.64	0.59	0.48	0.64	0.24	0.59	0.32	0.29	0.34

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Net Cash Provided By Used In Financing Activities		0.22	0.70	0.16	273.33	0.28	216.30	10.43	-0.15	0.52	0.45	0.19	1.37	0.24	-2.37	163.64	51.70

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31
Novartis, Novartis Agreement		0.00	-3.40	0.20	1.30	2.00	1.50	1.60	1.20	2.00	1.60	1.80	2.20	4.40	4.80	3.60	3.90
Revenue From Contract With Customer Excluding Assessed Tax		0.00	0.00	0.25	1.33	1.97	1.48	4.99	1.25	2.00	1.61	1.79	2.17	4.46	4.81	3.60	28.94

Plots across concepts

Line plots across dimensions of each concept